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A B S T R A C T
Background: Mutation of NKX2-5 could lead to the development of congenital heart disease (CHD) which
is a common inherited disease. This study aimed to investigate the pathogenesis of CHD in NKX2-5
knock-out embryonic mice.
Methods: The expression proﬁle in the NKX2-5 knock-out embryonic mice (GSE528) was downloaded
from Gene Expression Omnibus. The heart tissues from the null/heterozygous embryonic day 12.5 mice
were compared with wild-type mice to identify differentially expressed genes (DEGs), and then DEGs
corresponding to the transcriptional factors were ﬁltered out based on the information in the TRANSFAC
database. In addition, a transcriptional regulatory network was constructed according to transcription
factor binding site information from the University of California Santa Cruz database. A pathway
interaction network was constructed by latent pathways identiﬁcation analysis.
Results: The 42 DEGs corresponding to transcriptional factors from the null and heterozygous embryos
were identiﬁed. The transcriptional regulatory networks included ﬁve down-regulated DEGs (SP1, SRY,
JUND, STAT6, and GATA6), and six up-regulated DEGs [POU2F1, NFY (NFYA/NFYB/NFYC), USF2 and MAX].
Latent pathways analysis demonstrated that ribosome, glycolysis/gluconeogenesis, and dilated
cardiomyopathy pathways signiﬁcantly interacted.
Conclusion: The identiﬁed DEGs and latent pathways could provide new comprehensive view for
understanding the pathogenesis of CHD.
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Cardiovascular disease is the leading cause of mortality
worldwide [1]. Congenital heart defect (CHD) is deﬁned as the
defective structure of heart and great vessels and the incidence of
CHD could reach up to 1% in newborns [2,3]. The developmental
process of the heart is complicated, requiring accurate expression
of related genes over time and space, among which the
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and parallelly cardiac primordia develop, which form the primitive
heart tube along the ventral midline of the embryo [4,5].
Cardiac development originates from a series of rhythmical
gene expressions which are concisely controlled by the transcrip-
tion factors. Most of the known causes of CHD are sporadic genetic
changes, for example, mutations of a-myosin heavy chain (MYH6)
are associated with cardiac defects [6]. Many research results have
indicated that transcriptional factors, such as NKX2-5, GATA, and
TBX, play vital roles in the occurrence and development of CHD [7–
10]. Among the NK2 family, NKX2-3, NKX2-5, NKX2-7, NKX2-8, and
NKX2-10 are related to the development of the heart and NKX2-5
has attracted more attention [11,12]. Cardiac homeobox gene
NKX2-5 (also called Csx1) has been conﬁrmed to be closely related
to CHD [13]. Unknown mechanisms could be responsible for why
human mutations in NKX2-5 lead to progressive cardiomyopathy
and conduction defects. Previously, NKX2-5 was identiﬁed in
zebraﬁsh and mice [14,15]. However, Gioli-Pereira et al. [16]
evaluated the presence of mutations in the NKX2-5 in 159 patients reserved.
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and found that there was no absolute association between NKX2-5
and CHD.
In order to explore the pathogenesis of CHD, we applied
bioinformatics methods to analyze the expression proﬁling of
GSE528. Schinke et al. created a NKX2-5 knock-out mouse by Cre/
loxP mediated excision. Homozygous mutant mice die at
embryonic day 14.5 because of severe cardiac malformations,
while heterozygous mutant mice demonstrate the cardiac defects
associated with cardiac septation and valve morphogenesis
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE528).
The expressional proﬁle of wild embryos, NKX2-5 knock-out null
embryonic mice and heterozygous embryonic mice, were analyzed
to select the differentially expressed genes (DEGs). Then relevant
DEGs corresponding to transcription factors were ﬁltered out
based on the information in the TRANSFAC database [17]. Further-
more latent pathway identiﬁcation analysis was applied to identify
the interactions between the pathways. Finally, transcriptional
regulatory network and latent pathway interaction networks were
constructed.
Materials and methods
Data sources
The gene expressional proﬁle of GSE528 from mice was
downloaded from Gene Expression Omnibus (GEO, http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE528). The platforms
were GPL75 and GPL76 [Mu11KsubA] Affymetrix Murine 11K
SubA Arrays. Ten heart tissue samples were applied in this study,
including four samples from wild-type embryonic day 12.5 mice,
three from NKX2-5 knock-out heterozygous embryonic day
12.5 mice, and three from NKX2-5 knock-out null embryonic
day 12.5 mice.
Preprocessing of expression data
Preprocessing of the expression proﬁle matrix was ﬁrst
performed. If there was at least one missing expression value for
one probe, the probe was discarded. According to the annotation
information from platform, probe name was converted to a gene
name, and expression values of multiple probes corresponding to
the same gene were averaged.
Identiﬁcation of DEGs
In order to get the DEGs, the heart tissue samples of wild
embryos, NKX2-5 knock-out null embryonic mice, and NKX2-5
knock-out heterozygous embryonic mice were performed in a
pairwise comparison with Limma package of R language [18], and
screening criteria were adjusted with a p-value <0.05, and
jlog2 FCj > 0.585.
Screening of the transcription factors in DEGs
DEGs corresponding to transcription factors were obtained
according to information from TRANSFAC database [17] and target
genes of transcription factors according to binding sites informa-
tion were provided by the University of California Santa Cruz
(UCSC) database (http://genome.ucsc.edu/).
Latent pathways identiﬁcation analysis
Latent pathways identiﬁcation analysis [19] was applied to
identify the interactions between the pathways in which DEGs
were involved. The stronger the signiﬁcance of interaction was, themore relevant was the relationship between the pathways and
diseases. Firstly, the clusterProﬁler package of R language was
applied to identify all gene ontology (GO) terms biological process
(BP) (later referred to as G) and KEGG pathways (referred to as P) in
which DEGs were involved. The expressed values of DEGs were
obtained according to microarray expression proﬁle. Secondly, the
bipartite network of G and P was built. One node of the line was P
and the other side was G. The edges represented DEGs that were
both involved in the G and P. The weight of edge was determined by
two parts: (1) the relative overlap of P and G, presented as Jaccard
similarity coefﬁcient [20]; (2) the expression values of DEGs were
averaged. The weight formula was as follows:
wGP ¼ G \ PG [ P







 medfDEx : x 2 G \ Pg
wherein P represents KEGG pathway; G represents GO BP term;
jðG \ PÞ=ðG [ PÞj represents Jaccard similarity coefﬁcient of P and G;
and DE represents expression values of DEGs. G [ P represents all
genes involved in pathway P and G; G \ P represents the genes
involved in G and P. Thirdly, based on bipartite pathway network, if
there is at least one common BP term between the two pathways,
they will be connected. The weight of edge was calculated according
to Ai j ¼
PG
k¼1wGkPi  wGkP j . Fourthly, the interaction of pathways in
the network was calculated by random walk method. The criterion
for the signiﬁcant interaction pathways was p-value <0.05.
Transcriptional regulatory networks and potential pathways
interaction networks
The transcriptional regulatory networks were constructed and
the latent pathway interaction networks were built according to
the weight of pathway interactions using Cytoscape software
(Cytoscape 3.X; http://www.cytoscape.org) [21].
Results
Expression matrix normalization and screening of DEGs and
transcription factors
The expression proﬁle matrixs before and after normalization
were shown in Fig. 1. The normalized median line after
normalization was almost in a straight line, indicating that
normalization was successful.
The genes with jlog2 FCj > 0.585 and p-value <0.05 were
selected as signiﬁcant DEGs. Information of transcription factors
was obtained from TRANSFAC database. Table 1 shows the number
of up-regulated DEGs, down-regulated DEGs, and their corre-
sponding transcription factors in heterozygous and null embryonic
mice compared with wild embryonic mice.
Latent pathways analysis
To explore the interactions between the pathways affected by
DEGs in NKX2-5 knock-out embryonic mice, the associated network
between the pathways was constructed and a total of 8361 inter-
actions involving 130 pathways in NKX2-5 knock-out heterozygous
embryos were selected. A total of 8385 interactions involving
130 pathways in NKX2-5 knock-out null embryos were screened.
Figs. 2 and 3 showed the interaction network of latent
pathways, demonstrating that there were 13 signiﬁcant pathways
in heart tissue from heterozygous embryos and null embryos. The
signiﬁcance of pathways in the interaction network was evaluat-
ed. Thirteen pathways with p-value <0.05 were identiﬁed
in heterozygous embryos (Table 2) and thirteen pathways with
p-value <0.05 were identiﬁed in null embryonic heart tissue
Fig. 1. The expression cassette of samples before normalization (A) and after normalization (B). The horizontal axis indicates the name of the samples, and the ordinate axis
represents the expression values. The black lines in each cassette are the median of data.
Table 1
The number of differentially expressed genes (DEGs) and their corresponding
transcription factors (TF).
ID Up-DEG/TF Down-DEG/TF
Heterozygous vs. wild embryo 970/46 1063/46
Null vs. wild embryo 983/45 1052/45
Overlap 391/21 403/21
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gluconeogenesis, pyruvate metabolism, cardiac muscle contrac-
tion, porphyrin and chlorophyll metabolism, fructose and
mannose metabolism, hypertrophic cardiomyopathy, and dilated
cardiomyopathy pathways.Fig. 2. The interaction network of pathways that were involved in the differentially
expressed genes (DEGs) in NKX2-5 knock-out heterozygous embryonic day
12.5 mice. Red diamonds represent pathways and the edges represent
interactions between pathways. (For interpretation of the references to color in
this ﬁgure legend, the reader is referred to the web version of the article.)Construction of transcriptional regulatory networks
The 42 common up-regulated and down-regulated transcrip-
tion factors in heterozygous and null embryonic mice were
identiﬁed, and transcriptional regulatory networks were con-
structed according to the transcription factor binding sites
information provided by the UCSC database. As can be seen from
Fig. 4, 11 DEGs corresponding to transcription factors and
regulatory target genes formed the umbrella regulatory networks.
SP1 (speciﬁcity protein 1), SRY (sex-determining region Y, testisFig. 3. The interaction network of pathways that were involved in the differentially
expressed genes (DEGs) in NKX2-5-knocked null embryonic day 12.5 mice. Red
diamonds represent pathways and the edges represent interactions between
pathways. (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of the article.)
Table 2
The signiﬁcant pathways that differentially expressed genes in NKX2-5 knock-out
heterozygous embryonic day 12.5 mice involved by latent pathways analysis.
KEGG pathway ID Description p-Value Degree
mmu03010 Ribosome 0.000 129
mmu00010 Glycolysis/gluconeogenesis 0.000 129
mmu00620 Pyruvate metabolism 0.004 128
mmu04260 Cardiac muscle contraction 0.006 128
mmu00860 Porphyrin and chlorophyll metabolism 0.010 129
mmu00051 Fructose and mannose metabolism 0.020 129
mmu05414 Dilated cardiomyopathy 0.024 129
mmu05410 Hypertrophic cardiomyopathy (HCM) 0.026 128
mmu00270 Cysteine and methionine metabolism 0.026 129
mmu04146 Peroxisome 0.028 129
mmu00640 Propanoate metabolism 0.040 128
mmu00480 Glutathione metabolism 0.042 129
mmu03040 Spliceosome 0.042 129
Table 3
The signiﬁcant pathways that differentially expressed genes in NKX2-5 knock-out
null embryonic day 12.5 mice involved by latent pathways analysis.
KEGG pathway ID Description p-Value Degree
mmu03010 Ribosome 0.000 129
mmu00010 Glycolysis/gluconeogenesis 0.000 129
mmu04260 Cardiac muscle contraction 0.002 129
mmu00620 Pyruvate metabolism 0.002 129
mmu00051 Fructose and mannose metabolism 0.014 129
mmu00860 Porphyrin and chlorophyll metabolism 0.022 129
mmu05410 Hypertrophic cardiomyopathy (HCM) 0.024 129
mmu00270 Cysteine and methionine metabolism 0.024 129
mmu00640 Propanoate metabolism 0.028 129
mmu05414 Dilated cardiomyopathy 0.032 129
mmu03040 Spliceosome 0.032 129
mmu00030 Pentose phosphate pathway 0.040 129
mmu00480 Glutathione metabolism 0.049 129
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and POU2F1 (POU class 2 homeobox 1 gene), NFY (nuclear factor Y)
(NFYA/NFYB/NFYC), USF2 (upstream stimulatory factor 2), and MAX
were up-regulated.Fig. 4. Regulatory network of transcription factors with the same trend and their
target genes in NKX2-5 knock-out heterozygous and null embryonic mice. Red
nodes represent up-regulated genes corresponding to transcription factors; green
nodes represent down-regulated genes corresponding to transcription factors;
purple nodes represent regulatory target genes. (For interpretation of the references
to color in this ﬁgure legend, the reader is referred to the web version of the article.)Discussion
CHD includes congenital malformations caused by fetal
abnormalities in heart and great vessels during childhood
[22]. In our study, a total of 42 common up-regulated and
down-regulated DEGs corresponding to transcription factors were
identiﬁed in NKX2-5 knock-out heterozygous and null embryonic
mice compared with wild type.
In the latent pathway interactions network, signiﬁcant path-
ways included ribosome, glycolysis or gluconeogenesis, pyruvate
metabolism, cardiac muscle contraction, porphyrin and chloro-
phyll metabolism, fructose and mannose metabolism, hypertro-
phic cardiomyopathy, and dilated cardiomyopathy pathways. It
has been reported that the synthesis of ribosome was accelerated
in cardiac hypertrophy in the rat heart [23]. DEGs were involved
in glycolysis or gluconeogenesis, pyruvate metabolism, and
fructose and mannose metabolism, indicating that the energy
metabolism was changed in mice after the NKX2-5 knock-out.
Dilated cardiomyopathy and hypertrophic cardiomyopathy were
also the signiﬁcant pathways in the pathways interaction
network. Thus, the expression genes involved in the dilated and
hypertrophic cardiomyopathy may be related to CHD.
In the regulatory network of transcription factors and target
genes, SP1, SRY, JUND, STAT6, and GATA6 were down-regulated, and
POU2F1, NFY (NFYA/NFYB/NFYC), USF2, and MAX were up-regulated.
Lack of JUND could promote dilated cardiomyopathy in fra-1
transgenic mice [24]. GATA6, encoding a cardiac transcription
factor, is extensively expressed in developing heart and non-
synonymous GATA6 variants (A178V and L198V) were not found in
control population but identiﬁed in two individuals with CHD
[25]. But there were no reports about the association of other
transcription factors with CHD. Cyclooxygenase-2 (COX-2) is
expressed in the heart failure and overexpression of SP1 that is a
transactivation factor could enhance the cox-2 promoter activity
[26]. STAT6 is activated when ischemic injury of heart is induced
[27]. Although there was no direct evidence, their association with
heart disease or heart development may imply their potential roles
in CHD. No reports were found about the relation between SRY,
POU2F1, NFY (NFYA/NFYB/NFYC), USF2, MAX, and heart disease or
heart development. However, we could speculate that the
transcription factors identiﬁed in our study may be related to
CHD, providing potential view for the pathogenesis of NKX2-5
knock-out CHD.
In conclusion, latent pathways analysis indicated that knock-
out of NKX2-5 in embryonic mice could impact ribosome pathway,
energy metabolism process, myocardium development, and
providing a new and comprehensive view for pathogenesis of
CHD. The transcription factors SP1, JUND, STAT6, and GATA6 may be
related to CHD. However, the function of genes and pathways
identiﬁed in our study needs large experiments to investigate their
roles in the NKX2-5 knock-out CHD.
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